Selected article for: "antibody fragment and chain variable fragment"
Author: Zhao, Aizhi; Qin, Weijun; Han, Yueheng; Wen, Weihong; Zhang, Wenhong; Lian, Zhonghui; Chen, Gang; Zhang, Zhuoli; Peng, Jianqiang; Wang, He; Guo, Yinglu
Title: Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV
  • Cord-id: mfrsk8mz
  • Document date: 2007_4_21
    • ID: mfrsk8mz
    Snippet: To develop reagents for early diagnosis and therapeutic drugs against SARS-associated coronavirus (SARS-CoV), a large (3 × 10(9)) immunized human antibody library was constructed from peripheral blood mononuclear cells from six SARS convalescent patients. A single chain variable fragment antibody (N18) with high affinity against N protein of SARS-CoV was isolated. Sequence analysis revealed that the VL gene was composed of VL3 h (V lambda subgroup) and JL2 regions and the VH gene was composed o
    Document: To develop reagents for early diagnosis and therapeutic drugs against SARS-associated coronavirus (SARS-CoV), a large (3 × 10(9)) immunized human antibody library was constructed from peripheral blood mononuclear cells from six SARS convalescent patients. A single chain variable fragment antibody (N18) with high affinity against N protein of SARS-CoV was isolated. Sequence analysis revealed that the VL gene was composed of VL3 h (V lambda subgroup) and JL2 regions and the VH gene was composed of VH1-69 (VH1 subgroup), D2-15, D3-22 and JH6 regions. Soluble N18 antibody was expressed in Escherichia coli HB2151, purified by Ni–NTA affinity chromatography and verified by SDS-PAGE and Western blot. The potential application for early diagnosis was evaluated using N protein capture ELISA in which N18 antibody demonstrated high sensitive activity in detecting N protein of SARS-CoV. Finally, the potential usefulness of the N18 antibody in prophylaxis, vaccine design and therapy of SARS is discussed.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and long unique: 1, 2, 3, 4
    • acute respiratory syndrome and low concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lysis buffer: 1, 2, 3
    • acute respiratory syndrome and mab monoclonal antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • long sequence and low concentration: 1
    • long sequence and lysis buffer: 1
    • low concentration and lysis buffer: 1, 2
    • low concentration and mab monoclonal antibody: 1